Prostaron

Remedica Ltd. (Building 10-Antineoplastic & Immunomodulating Products)🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 61fab96cdf644d8a
Company: Remedica Ltd. (Building 10-Antineoplastic & Immunomodulating Products)
Type: Standard

Approval Id: 61fab96cdf644d8a
Drug Approval Philippines Name: Prostaron
Product Name: Prostaron
Registration Number: DRP-16398
Brand Name: Prostaron
Generic Name: Abiraterone acetate
Dosage Form: Film-Coated Tablet
Dosage Strength: 250 mg
Manufacturer: Remedica Ltd. (Building 10-Antineoplastic & Immunomodulating Products)
Issuance Date: 27 February 2025
Expiry Date: 27 February 2030
Pharmacologic Category: Endocrine Therapy
Classification: Prescription Drug (Rx)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

61fab96cdf644d8a

Type

Standard